Institut Pasteur Korea is an infectious disease-focused research institute established in April 2004 as part of the Korea-France scientific exchange. With support from the Korean Ministry of Science and ICT (MSIT), it was founded through the agreement between the Institut Pasteur (Paris) and the Korea Institute of Science and Technology (KIST).
To contribute to global public health, multinational researchers from over 10 countries strive to understand the mechanisms of infectious diseases and help develop new treatments and preventive strategies utilizing state-of-the-art technology and research infrastructure.
Utilizing its advanced R&D resources, IPK makes its core technology and know-how, such as drug discovery screening (HTS/HCS) platforms, available for the domestic and international biomedical communities and facilitates translational research that bridges excellent basic research results to the pharmaceutical industry.
As a member of the Pasteur Network, a global infectious disease research network with a history of more than 130 years, IPK plays a key role as a pivotal center for drug discovery in the Asia-Pacific region and contributes to global infectious diseases preparedness and response.
Furthermore, IPK reinforces Korea’s scientific resources and knowledge by connecting international and domestic pharmaceutical communities and promoting international research cooperation.